EUCTR2011-005495-42-DK
Active, not recruiting
Not Applicable
Individualised first line chemotherapy in metastatic colo-rectal cancer (mCRC).Is plasma TIMP-1 a predictive factor for best choise of first line chemotherapy in mCRC? - Individualised choise of 1.line chemotherapy in metastatic colo-rectal cancer
Kell Osterlind0 sites210 target enrollmentApril 18, 2012
ConditionsMetastatic colon or rectal cancerMedDRA version: 14.1Level: PTClassification code 10027457Term: Metastases to liverSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Metastatic colon or rectal cancer
- Sponsor
- Kell Osterlind
- Enrollment
- 210
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically proven colon or rectal cancer
- •Metastatic disease primary (stage IV) or due to relapse of previous (resected) stage I\-III disease
- •At least 1 measurable lesion
- •18 years of age or older
- •WHO performance status \<3
- •Expected survival \>3 months
- •Hgb\>6\.1 mmol/L, WBC\>2\.9, platelets\>99
- •Kidney and liver function tests below certain defined upper limits
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
Exclusion Criteria
- •Previous chemotherapy (including adjuvant after primary surgery)
- •Previous cancer (except non melanoma skin cancer)
- •Allergy to any of the therapeutical substances
- •Neuropathy (e.g. alcoholic or diabetic)
- •Recent myocardial infarction or stroke
- •Uncontrollable hypertension
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Sequential first-line therapy in metastatic colorectal cancer with Capecitabine/FUFA, Irinotecan and Bevacizumabmetastatic colorectal cancerMedDRA version: 20.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2009-013099-38-DEKlinikum der Universität München, Anstalt des öffentlichen Rechts vertreten durch den Vorstand450
Not yet recruiting
Phase 3
A study to see effectiveness of chemotherapy for older patients with lung cancer.Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecifiedCTRI/2022/07/044193Tata Memorial Hospital
Active, not recruiting
Not Applicable
Dosisdichte 1st-line Therapie des metastasierten Mammakarzinoms mit Paclitaxel und liposomalem Doxorubicin (Myocet®)metastasiertes MammakarzinomMedDRA version: 9.1Level: LLTClassification code 10006187Term: Breast cancerEUCTR2005-004234-41-DEOtto-von-Guericke Universität Magdeburg
Active, not recruiting
Not Applicable
Individual Therapy by Gene Expression for Colon Cancer PatientsEUCTR2012-001307-20-ESFundación Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO)
Active, not recruiting
Not Applicable
Intensive chemo-immunotherapy as first-line treatment in adult patients with peripheral T-cell Lymphoma PTCL - PTCL intensive chemo-immunotherapyon Hodgkin peripheral T-cell lymphomasMedDRA version: 6.1Level: PTClassification code 10034623EUCTR2006-004234-33-ITISTITUTO NAZIONALE PER LA CURA TUMORI111